FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3873516 · Received June 14, 2014

Report

Report Number
1416980-2014-18999
Event Type
Injury
Date Received
June 14, 2014
Date of Event
April 3, 2014
Report Date
May 21, 2014
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS THE SAMPLE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN, A DEVICE ANALYSIS CANNOT BE COMPLETED. THE CAUSE OF THIS PERITONITIS WAS USE ERROR REPORTED TO BE DUE TO A BREAK IN ASEPTIC TECHNIQUE BY THE PATIENT. PER BAXTER LABELING, USERS ARE INSTRUCTED TO USE ASEPTIC TECHNIQUE WHEN PERFORMING PERITONEAL DIALYSIS THERAPY. A FORMAL REVIEW OF THE LABEL FOR THE PRODUCT FAMILY WILL BE CONDUCTED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED A BREAK IN ASEPTIC TECHNIQUE FURTHER DESCRIBED AS THE PATIENT CAUSING A TOUCH CONTAMINATION DURING PERITONEAL DIALYSIS (PD) THERAPY, WHICH CAUSED BACTERIAL PERITONITIS. THE PATIENT WAS TREATED WITH VANCOMYCIN (DOSE, FREQUENCY AND ROUTE NOT REPORTED) AND FORTAZ (DOSE, FREQUENCY AND ROUTE NOT REPORTED) FOR PERITONITIS. THE PATIENT WAS ALSO RETRAINED ON ASEPTIC TECHNIQUE. THE FOLLOWING MONTH AFTER THE ONSET OF PERITONITIS, THE PATIENT WAS HOSPITALIZED AS THE PERITONITIS HAD NOT RESOLVED. ON AN UNREPORTED DATE, THE PD CATHETER WAS REMOVED DUE TO PERITONITIS. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL EIGHT DAYS LATER. AT THE TIME OF THIS REPORT, THE PATIENT WAS RECOVERING FROM THE PERITONITIS. THE PD THERAPY WAS DISCONTINUED. ADDITIONAL INFORMATION WAS REQUESTED BUT WAS NOT AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
351729 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 75 YR Hospitalization| R DIANEAL 1.5% PD4 ULTRABAG| DIANEAL 1.5% PD4 AMBUFLEX